Samsung unveiled quite possibly its most robust and feature-packed Apple Watch alternative to date nearly eight months ago, but while our in-depth review and head-to-head comparison confirmed the Galaxy Watch Active 2 was indeed a worthy contender for the Series 5's title of best smartwatch in the world, something big was missing to completely level the playing field.
We even heard whispers of a February software update looking to activate the dormant life-saving hardware, but unfortunately, that hasn't proven to be the case, and worse yet, Samsung is staying completely mum on the matter.
All signs seem to point to some sort of a delay in the FDA approval process, including a reply from a company "product expert" in one of multiple Samsung Community threads where people are complaining of false advertising and even threatening legal action if they don't soon get what they were promised back when the Galaxy Watch Active 2 was released.
The device is also listed as "not approved or cleared by U.S. FDA" in the documentation of a clinical trial scheduled to start on May 1, 2020 and end on May 1, 2030, although you should keep in mind those dates probably have nothing to do with the potential rollout of the aforementioned ECG-enabling software update.
Meanwhile, the folks over at TizenHelp spotted another Samsung Community reply from a "Health Manager" claiming to be the "person in charge of operation of Samsung Health Service", who says the company is "currently preparing for the electrocardiogram service through Galaxy Watch Active 2", warning however that it may still "take time to provide stable service."
In other words, it sounds like no one knows when the feature will become active (pun very much intended), and the uncertainty over the FDA approval could well be exacerbated by the ongoing coronavirus outbreak. Keep in mind that Samsung absolutely needs the US Food and Drug Administration's green light to provide electrocardiogram measurements on the wrists of Galaxy Watch Active 2 owners, which can reveal serious heart conditions like atrial fibrillation and tachycardia, potentially saving or at least improving many lives.
Adrian, a mobile technology enthusiast since the Nokia 3310 era, has been a dynamic presence in the tech journalism field, contributing to Android Authority, Digital Trends, and Pocketnow before joining PhoneArena in 2018. His expertise spans across various platforms, with a particular fondness for the diversity of the Android ecosystem. Despite the challenges of balancing full-time parenthood with his work, Adrian's passion for tech trends, running, and movies keeps him energized. His commitment to mid-range smartphones has led to an eclectic collection of devices, saved from personal bankruptcy by his preference for 'adequate' over 'overpriced'.
Recommended Stories
Loading Comments...
COMMENT
All comments need to comply with our
Community Guidelines
Phonearena comments rules
A discussion is a place, where people can voice their opinion, no matter if it
is positive, neutral or negative. However, when posting, one must stay true to the topic, and not just share some
random thoughts, which are not directly related to the matter.
Things that are NOT allowed:
Off-topic talk - you must stick to the subject of discussion
Offensive, hate speech - if you want to say something, say it politely
Spam/Advertisements - these posts are deleted
Multiple accounts - one person can have only one account
Impersonations and offensive nicknames - these accounts get banned
Moderation is done by humans. We try to be as objective as possible and moderate with zero bias. If you think a
post should be moderated - please, report it.
Have a question about the rules or why you have been moderated/limited/banned? Please,
contact us.
FCC OKs Cingular\'s purchase of AT&T Wireless
Things that are NOT allowed: